secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001801170-26-000114
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health posts Q1 GAAP net income of $27M; revenue up 62% YoY
------------------------------------------------------------------

- GAAP net income $27.3M vs $(1.3)M in Q1 2025; first positive GAAP net income quarter.
- Total revenue $749M (+62% YoY); Medicare Advantage membership 155,773 (+51% YoY).
- Consolidated Gross Profit $159.5M (+47% YoY); Adjusted EBITDA $40.3M (+56% YoY).
- Full-year 2026 guidance: revenue $2.81B-$2.92B, GAAP net income $0M-$20M.
- Expects to meet or exceed full-year outlook with first full year of GAAP net income profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/0001801170-26-000114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000114/clov-20260506.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer